Transition of AKI to CKD | p-value | ||
---|---|---|---|
Negative (n = 201) | Positive (n = 51) | ||
CBC | |||
Hemoglobin (g/dl) | 9.71 ± 2.9 | 9.22 ± 2.5 | = 0.364* |
WBCs*103/l | 14 (1–59) | 15 (2.5–48) | = 0.350** |
Platelet*103/l | 200 (4–1058) | 235 (11–500) | = 0.145** |
KFT | |||
BUN (mmol/l) | 26 (6–79) | 31 (12–87) | = 0.024** |
S. creatinine (µmol/l) | 296 (171–1576) | 412 (187–1456) | = 0.002** |
Blood electrolytes | |||
Na (mEq/l) | 134.47 ± 8.6 | 133.29 ± 9.1 | = 0.417* |
K (mmol/l) | 4 (1–8) | 4.5 (1–10) | = 0.049** |
Ca (mg/dl) | 8.5 (3–11) | 8.2 (3–9.5) | = 0.123** |
PO4 (mg/dl) | 3 (1–13) | 4 (1–10) | = 0.002** |
Mg (mg/dl) | 2 (1.1–5.5) | 2 (1–5) | = 0.598** |
LFT | |||
AST (U/l) | 53 (6–3569) | 59 (14–3689) | = 0.479** |
ALT (U/l) | 40 (6–4182) | 43 (10–3120) | = 0.735** |
Albumin (g/l) | 30 (3–129) | 31 (19–45) | = 0.060** |
TB (µmol/l) | 10 (1–339) | 9 (1–132) | = 0.532** |
DB (µmol/l) | 6 (0.1–282) | 4 (0.4–107) | = 0.392** |
Coagulation profile | |||
PT(s) | 16 (11–43) | 15.5 (11–34) | = 0.811** |
PC | 56 (19–104) | 61.5 (21–77) | = 0.858** |
INR | 1.5 (1.1–3.9) | 1.3 (1.1–3.3) | = 0.447** |
Serpin level | |||
Serum serpin (ng/ml) | 74 (57.5–307) | 169.5 (118–171) | = 0.015** |
Urinary serpin (ng/ml) | 67 (40.5–147) | 150 (114–282) | = 0.005** |
Urine analysis | |||
PUS | 12 (1–100) | 20 (5–100) | = 0.001** |
RBCs | 5 (0–100) | 5 (1–100) | = 0.954** |
Other findings | |||
• Cast | 5 (2.5%) | 2 (4%) | = 0.824*** |
• Albumin | 57 (28.4%) | 15 (29.4%) | = 0.882$ |
• 24-h protein | 14 (7%) | 4 (7.8%) | = 0.828*** |
Imaging | |||
Abnormal findings | |||
• U/S | 79 (39.3%) | 24 (47.1%) | = 0.048$ |
• Chest CT | 107 (53.2%) | 29 (56.9%) | = 0.380$ |
• Echo | 67 (33.3%) | 29 (56.9%) | = 0.002$ |
Renal biopsy | |||
• Yes | 5 (2.5%) | 1 (2%) | = 0.649*** |